Skip to main content

Saad Mark E's Form 4 filing

Axsome Therapeutics, Inc. (AXSM) · filed Jan 2, 2026

Accession no.
0001193125-26-001181
Filed
Jan 2, 2026
Trade date
Dec 31, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.21M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Saad Mark ECIK 0001295913Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 31, 2025Common StockMOption exerciseAcquired+6,231$8.02+$49,972.6216,233Direct
Dec 31, 2025Common StockSSaleDisposed−6,231$165.18F4−$1,029,236.5810,002Direct
Dec 31, 2025Common StockMOption exerciseAcquired+31,346$4.95+$155,162.741,348Direct
Dec 31, 2025Common StockSSaleDisposed−31,346$165.18F4−$5,177,732.2810,002Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 31, 2025Common StockMOption exerciseDisposed−6,231$0.00$00Direct
Dec 31, 2025Common StockMOption exerciseDisposed−31,346$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)